147 related articles for article (PubMed ID: 38327406)
1. Activated CD4 T cells/Tregs derived immune-metabolism signature provide precise prognosis assessment for gastric cancer and beneficial for treatment option.
Huo J; Shang Z; Fan X; Sun P
Heliyon; 2024 Feb; 10(3):e25463. PubMed ID: 38327406
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy Efficacy-related Risk Classifier Differentiate Prognostic Characteristics of Gastric Cancer-A Large-scale Retrospective Study.
Huo J; Fan X; Sun W; Sun P
J Immunother; 2023 Oct; 46(8):323-332. PubMed ID: 37469271
[TBL] [Abstract][Full Text] [Related]
3. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
Huo J; Xie W; Fan X; Sun P
Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of 1804 samples of six centers to construct and validate a robust immune-related prognostic signature associated with stromal cell abundance in tumor microenvironment for gastric cancer.
Huo J; Guan G; Cai J; Wu L
World J Surg Oncol; 2022 Jan; 20(1):4. PubMed ID: 34983559
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages.
Huo J; Wu L; Zang Y
Front Oncol; 2021; 11():635324. PubMed ID: 34178625
[TBL] [Abstract][Full Text] [Related]
6. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer.
Huo J; Wu L; Zang Y
J Immunol Res; 2021; 2021():5554342. PubMed ID: 34007851
[TBL] [Abstract][Full Text] [Related]
8. Metabolism reprogramming signature associated with stromal cells abundance in tumor microenvironment improve prognostic risk classification for gastric cancer.
Huo J; Guan J; Li Y
BMC Gastroenterol; 2022 Jul; 22(1):364. PubMed ID: 35907819
[TBL] [Abstract][Full Text] [Related]
9. Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database.
Huo J; Wu L; Zang Y
J Transl Med; 2021 Apr; 19(1):183. PubMed ID: 33926488
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
Chen T; Yang C; Dou R; Xiong B
Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
[TBL] [Abstract][Full Text] [Related]
11. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
12. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
13. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.
Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C
Front Immunol; 2023; 14():1117255. PubMed ID: 37457685
[TBL] [Abstract][Full Text] [Related]
14. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancer.
Wu LH; Wang XX; Wang Y; Wei J; Liang ZR; Yan X; Wang J
Front Surg; 2023; 10():1088292. PubMed ID: 37066015
[TBL] [Abstract][Full Text] [Related]
16. DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer.
Shang Z; Wang Z; Zhang Y; Liu S
Transl Cancer Res; 2023 Oct; 12(10):2781-2805. PubMed ID: 37969400
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of cancer-associated fibroblast signature in gastric cancer.
Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C
Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716
[TBL] [Abstract][Full Text] [Related]
18. The role of senescence genes in the treatment, prognosis, and tumor microenvironment of gastric cancer.
Xuan J; Li F; Li J; Gong C; Li J; Mo Z; Jin Q
Am J Transl Res; 2023; 15(12):6926-6938. PubMed ID: 38187003
[TBL] [Abstract][Full Text] [Related]
19. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
20. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
